SS
NEUE

Steve Schonfeld’s NeueHealth NEUE Stock Holding History

Steve Schonfeld’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-140
Closed -$22K – 3077
2022
Q1 		$22K Buy
+140
New +$31.1K ﹤0.01% 2394
2021
Q3 		– Sell
-2,905
Closed -$3.99M – 2526
2021
Q2 		$3.99M Buy
+2,905
New +$3.98M 0.04% 524

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Steve Schonfeld's NEUE Position: Q2 2022 in Review

Steve Schonfeld sold out of NeueHealth (NEUE) in Q2 2022, closing a stake of 140 shares — an estimated $22K sold.

Steve Schonfeld first reported a position in NEUE in Q2 2021 and held it in 2 quarters. The position peaked at $3.99M in Q2 2021. 128 funds tracked by Wall St. Rank hold NEUE as of Q2 2022.

  • Steve Schonfeld reported no remaining NeueHealth position as of Q2 2022 after selling out during the quarter.
  • Steve Schonfeld sold 140 NeueHealth shares in Q2 2022, an estimated $22K.
  • Steve Schonfeld first reported a position in NeueHealth in Q2 2021 and held it in 2 quarters.
  • Steve Schonfeld's NeueHealth position peaked at $3.99M in Q2 2021.
  • 128 funds tracked by Wall St. Rank held NeueHealth as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.